Treatments

These posts deal with some the possible treatments for prostate cancer.

Home » Treatments

Prostate Imaging Reporting and Data System score of four or more: active surveillance no more

The introduction of multiparametric MRI (mpMRI) has improved the diagnosis and risk stratification of intermediate and high-risk prostate cancer. In addition to diagnosis, mpMRI has increasingly become a useful tool for monitoring the prostate cancer risk of patients on active surveillance (AS) programmes. Long-term data indicates that there is no oncological benefit for AS programmes for patients diagnosed with intermediate risk prostate cancer. Further, there is increasing evidence that PI-RADS 4 lesion on mpMRI correlates with intermediate and high-risk prostate cancer. Read the article here.

Prostate Imaging Reporting and Data System score of four or more: active surveillance no more Read More »

HIFU: Wave of the Future?

Dr. George Suarez, a Miami urologist, is unabashed in his enthusiasm for high-intensity focused ultrasound (HIFU), the use of ultrasound waves energy to destroy cancerous prostate cells. But not all urologists share in his excitement, and many express skepticism whether the benefits outweigh the risks. Dr. Peter Scardino, a urologist and chair of the Department of Surgery at Memorial Sloan Kettering Cancer Center, is one of them. “When I look at the results of HIFU for prostate cancer—which has been used in Europe for the last 15 years—what I see is cancer control rates that are no better than radiation

HIFU: Wave of the Future? Read More »

Preventing Overtreatment of Prostate Cancer: New Model Identifies Ideal Patients for Active Surveillance

A new care model for patients with low-risk prostate cancer may help prevent disease overtreatment. This evidence-based approach uses best practices to select patients to avoid disease overtreatment. Results from a 3-year study recently published in Urology indicate that active surveillance (AS) rates nearly doubled after this model was adopted. Read the article here.

Preventing Overtreatment of Prostate Cancer: New Model Identifies Ideal Patients for Active Surveillance Read More »

Hamilton study a “game changer” for prostate cancer treatment

A “game changer” study has concluded many prostate cancer patients need half as much radiation treatment as currently given. Ontario hospitals are already starting to change treatment to four weeks from the standard eight because of the study led by Hamilton’s Juravinski and Toronto’s Princess Margaret cancer centres. Read the article here.

Hamilton study a “game changer” for prostate cancer treatment Read More »

Laser ablation becomes increasingly viable treatment for prostate cancer

Up until now, capturing an image of a prostate cancer has been difficult because prostate tissue and tumor tissue are so similar. Precise, non-invasive surgical treatment has proved difficult as a result. Now UCLA researchers report that prostate cancer patients may soon have a new option to treat their disease: laser heat. Read the article here.

Laser ablation becomes increasingly viable treatment for prostate cancer Read More »

Video: A Surgeon and His Patient

September 2016 Awareness Night A Surgeon and His Patient – A Patient and His Surgeon Mark Cullen, Gardening Expert Radio and Television Personality and Best-selling Author Well-known newspaper and magazine columnist Member of the Order of Canada Prostate Cancer Survivor DR. GROLL’S PATIENT   Dr. Ryan Groll, MD, MSc, FRCPC Endourologist, Laparoscopic and Robotic Surgeon Michael Garron Hospital (Toronto East Health Network) (formerly Toronto East York General Hospital) Lectuter, Dept. of Surgery, U. of Toronto MARK CULLEN’S SURGEON   CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 52:22 minutes

Video: A Surgeon and His Patient Read More »

Scroll to Top